503 related articles for article (PubMed ID: 34066780)
1. Exosomal microRNAs as Biomarkers and Therapeutic Targets for Hepatocellular Carcinoma.
Sorop A; Constantinescu D; Cojocaru F; Dinischiotu A; Cucu D; Dima SO
Int J Mol Sci; 2021 May; 22(9):. PubMed ID: 34066780
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of exosomal microRNA-224 in development of hepatocellular carcinoma and its diagnostic and prognostic value.
Cui Y; Xu HF; Liu MY; Xu YJ; He JC; Zhou Y; Cang SD
World J Gastroenterol; 2019 Apr; 25(15):1890-1898. PubMed ID: 31057302
[TBL] [Abstract][Full Text] [Related]
3. Exosomal microRNAs in hepatocellular carcinoma, expanding research field.
Zheng BH; Ni XJ; Liu HB
World J Gastroenterol; 2024 May; 30(20):2618-2620. PubMed ID: 38855155
[TBL] [Abstract][Full Text] [Related]
4. Exosomal MiR-744 Inhibits Proliferation and Sorafenib Chemoresistance in Hepatocellular Carcinoma by Targeting PAX2.
Wang G; Zhao W; Wang H; Qiu G; Jiang Z; Wei G; Li X
Med Sci Monit; 2019 Sep; 25():7209-7217. PubMed ID: 31553714
[TBL] [Abstract][Full Text] [Related]
5. Exosomal miRNAs in hepatocellular carcinoma development and clinical responses.
Li S; Yao J; Xie M; Liu Y; Zheng M
J Hematol Oncol; 2018 Apr; 11(1):54. PubMed ID: 29642941
[TBL] [Abstract][Full Text] [Related]
6. Exosomes and Hepatocellular Carcinoma: From Bench to Bedside.
Sasaki R; Kanda T; Yokosuka O; Kato N; Matsuoka S; Moriyama M
Int J Mol Sci; 2019 Mar; 20(6):. PubMed ID: 30897788
[TBL] [Abstract][Full Text] [Related]
7. [Hepatocellular carcinoma-derived exosomal miRNA expression and its clinical value].
Wu MN; Sun JY; Yao M; Yao DF
Zhonghua Gan Zang Bing Za Zhi; 2020 Jan; 28(1):83-86. PubMed ID: 32023707
[TBL] [Abstract][Full Text] [Related]
8. The significance of exosomes in the development and treatment of hepatocellular carcinoma.
Li X; Li C; Zhang L; Wu M; Cao K; Jiang F; Chen D; Li N; Li W
Mol Cancer; 2020 Jan; 19(1):1. PubMed ID: 31901224
[TBL] [Abstract][Full Text] [Related]
9. Acidic Microenvironment Up-Regulates Exosomal miR-21 and miR-10b in Early-Stage Hepatocellular Carcinoma to Promote Cancer Cell Proliferation and Metastasis.
Tian XP; Wang CY; Jin XH; Li M; Wang FW; Huang WJ; Yun JP; Xu RH; Cai QQ; Xie D
Theranostics; 2019; 9(7):1965-1979. PubMed ID: 31037150
[No Abstract] [Full Text] [Related]
10. The exosome encapsulated microRNAs as circulating diagnostic marker for hepatocellular carcinoma with low alpha-fetoprotein.
Ghosh S; Bhowmik S; Majumdar S; Goswami A; Chakraborty J; Gupta S; Aggarwal S; Ray S; Chatterjee R; Bhattacharyya S; Dutta M; Datta S; Chowdhury A; Dhali GK; Banerjee S
Int J Cancer; 2020 Nov; 147(10):2934-2947. PubMed ID: 32441313
[TBL] [Abstract][Full Text] [Related]
11. Biological functions and clinical applications of exosomal non-coding RNAs in hepatocellular carcinoma.
Li C; Xu X
Cell Mol Life Sci; 2019 Nov; 76(21):4203-4219. PubMed ID: 31300868
[TBL] [Abstract][Full Text] [Related]
12. Exosomal Non-Coding RNAs: New Insights into the Biology of Hepatocellular Carcinoma.
Zhang Q; Li H; Liu Y; Li J; Wu C; Tang H
Curr Oncol; 2022 Jul; 29(8):5383-5406. PubMed ID: 36005165
[TBL] [Abstract][Full Text] [Related]
13. Exosome-transmitted long non-coding RNA
Wang J; Pu J; Zhang Y; Yao T; Luo Z; Li W; Xu G; Liu J; Wei W; Deng Y
Aging (Albany NY); 2020 Jun; 12(12):11550-11567. PubMed ID: 32602848
[TBL] [Abstract][Full Text] [Related]
14. The emerging role of microRNAs and long noncoding RNAs in drug resistance of hepatocellular carcinoma.
Wei L; Wang X; Lv L; Liu J; Xing H; Song Y; Xie M; Lei T; Zhang N; Yang M
Mol Cancer; 2019 Oct; 18(1):147. PubMed ID: 31651347
[TBL] [Abstract][Full Text] [Related]
15. Role of exosomes and exosomal microRNAs in hepatocellular carcinoma: Potential in diagnosis and antitumour treatments (Review).
Pan JH; Zhou H; Zhao XX; Ding H; Li W; Qin L; Pan YL
Int J Mol Med; 2018 Apr; 41(4):1809-1816. PubMed ID: 29328436
[TBL] [Abstract][Full Text] [Related]
16. Function and biomedical implications of exosomal microRNAs delivered by parenchymal and nonparenchymal cells in hepatocellular carcinoma.
Wang HC; Yin WX; Jiang M; Han JY; Kuai XW; Sun R; Sun YF; Ji JL
World J Gastroenterol; 2023 Oct; 29(39):5435-5451. PubMed ID: 37900996
[TBL] [Abstract][Full Text] [Related]
17. Circulating exosomal noncoding RNAs as prognostic biomarkers in human hepatocellular carcinoma.
Lee YR; Kim G; Tak WY; Jang SY; Kweon YO; Park JG; Lee HW; Han YS; Chun JM; Park SY; Hur K
Int J Cancer; 2019 Mar; 144(6):1444-1452. PubMed ID: 30338850
[TBL] [Abstract][Full Text] [Related]
18. Exosomal microRNAs as potential biomarkers for cancer cell migration and prognosis in hepatocellular carcinoma patient-derived cell models.
Yu LX; Zhang BL; Yang Y; Wang MC; Lei GL; Gao Y; Liu H; Xiao CH; Xu JJ; Qin H; Xu XY; Chen ZS; Zhang DD; Li FG; Zhang SG; Liu R
Oncol Rep; 2019 Jan; 41(1):257-269. PubMed ID: 30542726
[TBL] [Abstract][Full Text] [Related]
19. Targeting therapy for hepatocellular carcinoma by delivering microRNAs as exosomal cargo.
Suda T
World J Gastroenterol; 2024 May; 30(17):2369-2370. PubMed ID: 38813056
[TBL] [Abstract][Full Text] [Related]
20. Serum exosomal microRNAs as novel biomarkers for hepatocellular carcinoma.
Sohn W; Kim J; Kang SH; Yang SR; Cho JY; Cho HC; Shim SG; Paik YH
Exp Mol Med; 2015 Sep; 47(9):e184. PubMed ID: 26380927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]